NEW YORK, Nov. 22, 2013 /PRNewswire/ -- Effective today Empire Asset Management Company, a FINRA member (143007) terminated coverage of TrovaGene (NASDAQ:TROV). We are discontinuing coverage of TrovaGene Inc because the analyst covering the company is no longer associated with the firm. Shares of TrovaGene have been rated a buy since May 6, 2013. Investors should no longer rely on Empire Asset Management research for an investment recommendation on TrovaGene.
TrovaGene Inc closed on Thursday, November 21st at $5.51
SOURCE Empire Asset Management Company
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts